Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Measles
• Mumps
• Pertussis
• Rubella
• Tetanus
• Varicella

Drugs mentioned

• Diphtheria, Tetanus, and Pertussis (DTaP) vaccine (DTaP vaccine)
• Measles, Mumps, and Rubella (MMR) vaccine (MMR vaccine)
• Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella (chickenpox), MMR Vaccine | Phase 4 | Status: NOT_YET_RECRUITING